RFL News and Press, Rafael Holdings Inc. Class B From 08/30/21

Insider buying increased last week. Chief Executive Officer Howard S. Jonas purchases $5 million worth of shares of Rafael Holdings, Inc. Director Terry Considine continues to buy shares of Apartment Investment and Management Company. For further details see: Insider Wee...

CRANBURY, N.J., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, announced that Sanjeev Luther, President and CEO, will present at the World ...

Gainers: Aditxt ADTX +76%, BioLife Solutions (NASDAQ:BLFS) +15%, Virpax Pharmaceuticals (NASDAQ:VRPX) +10%, Flexion Therapeutics FLXN +9%, Rafael (NYSE:RFL) +7%. Losers: Cassava Sciences SAVA -22%, 111 (NASDAQ:YI) -15%, Owlet (NYSE:OWLT) ...

CRANBURY, N.J., Aug. 25, 2021 (GLOBE NEWSWIRE) -- -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, today announced the successful completion of a Phase 1b clinical trial of...

Rafael Holdings Announces Closing of $104.2 Million Private Placement PR Newswire NEWARK, N.J. , Aug. 24, 2021 /PRNewswire/ -- Rafael Holdings, Inc. (NYSE: RFL) today announced the closing of the previously announced private investment in public equity (PIPE...

Gainers: Greenpro Capital (NASDAQ:GRNQ) +61%. GeoVax Labs (NASDAQ:GOVX) +49%. Flora Growth Corp. (NASDAQ:FLGC) +31%. Pixelworks (NASDAQ:PXLW) +20%. XTL Biopharmaceuticals (NASDAQ:XTLB) +18%. Leju Holdings (NYSE:LEJU) +17%. Zhihu (NYSE:ZH) +17%. Organovo (NASDAQ:ONVO) +16%. Creatd (NASDAQ:CRTD...

Rafael Holdings Announces $104.2 Million Private Placement PR Newswire NEWARK, N.J. , Aug. 20, 2021 /PRNewswire/ -- Rafael Holdings, Inc. (NYSE: RFL) today announced that it has entered into definitive agreements to sell securities in a private placemen...

Rafael Holdings Expands Leadership Team with Three Highly Experienced Global Biopharmaceutical Executives to Build a Fully Integrated Cancer Metabolism Therapeutics Company Gus Kodersha appointed Chief Technical Operations Officer Melissa Lozner appointed Chief Compliance &a...

Andrews & Springer LLC , a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of Rafael Holdings, Inc. (NYSE: RFL) (“Rafael Holdings” o...

Kahn Brothers’ 13F portfolio value increased from $646M to $698M this quarter. BP plc and Pfizer were increased, while decreasing Nam Tai Property and BlackBerry during the quarter. The portfolio continues to be very concentrated with the top five positions accounting for ~...